A phase I clinical trial of a novel infectivity-enhanced suicide gene adenovirus with gene transfer imaging capacity in patients with recurrent gynecologic cancer

被引：0
|
作者：
Kim, K. [1 ]
Wang, M. [1 ]
Barnes, M. [1 ]
O'Malley, J. [1 ]
You, Z. [1 ]
Preuss, M. [1 ]
Siegal, G. [1 ]
Zinn, K. [1 ]
Curie, D. [1 ]
Alvarez, R. [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
来源：
GYNECOLOGIC ONCOLOGY | 2011年 / 121卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2010.12.077
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
70
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [1] A Phase I Clinical Trial of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Patients with Recurrent Gynecologic Cancer
    Kim, Kenneth H.
    Dmitriev, Igor
    O'Malley, Janis P.
    Wang, Minghui
    Saddekni, Souheil
    You, Zhiying
    Preuss, Meredith A.
    Harris, Raymond D.
    Aurigemma, Rosemarie
    Siegal, Gene P.
    Zinn, Kurt R.
    Curiel, David T.
    Alvarez, Ronald D.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3440 - 3451
  • [2] INFECTIVITY-ENHANCED ADENOVIRUSES FOR GENE THERAPY OF PATIENTS WITH RECURRENT OVARIAN AND OTHER SELECTED GYNECOLOGIC CANCERS
    Alvarez, R.
    Kim, K.
    Straughn, J. M.
    Huh, W.
    Estes, J. M.
    Dimitriev, I.
    Siegal, G.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [3] Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer and other selected gynecologic cancers
    Matthews, K. S.
    Noker, P.
    Tian, B.
    Grimes, S.
    Fulton, R.
    Schweikart, K.
    Harris, R.
    Aurigemma, R.
    Wang, M.
    Curiel, D. T.
    Alvarez, R. D.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S111 - S112
  • [4] Identifying the Safety Profile of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Anticipation of a Phase I Clinical Trial in Patients with Recurrent Ovarian Cancer
    Matthews, Kellie
    Noker, Patricia E.
    Tian, Baohong
    Grimes, Sheila D.
    Fulton, Ronna
    Schweikart, Karen
    Harris, Raymond
    Aurigemma, Rose
    Wang, Minghui
    Barnes, Mack N.
    Siegal, Gene P.
    Hemminki, Akseli
    Zinn, Kurt
    Curiel, David T.
    Alvarez, Ronald D.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (12) : 4131 - 4137
  • [5] A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent prostate cancer
    Nyati, Shyam
    Stricker, Hans
    Barton, Kenneth L.
    Li, Piln
    Elshaikh, Mohamed
    Ali, Haythem
    Brown, Stephen L.
    Hwang, Clara
    Peabody, James
    Freytag, Svend O.
    Movsas, Benjamin
    Siddiqui, Farzan
    [J]. CANCER RESEARCH, 2023, 83 (08)
  • [6] A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
    Kim, Kenneth H.
    Dmitriev, Igor P.
    Saddekni, Souheil
    Kashentseva, Elena A.
    Harris, Raymond D.
    Aurigemma, Rosemarie
    Bae, Sejong
    Singh, Karan P.
    Siegal, Gene P.
    Curiel, David T.
    Alvarez, Ronald D.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 130 (03) : 518 - 524
  • [7] Identifying the safety profile of Ad5/3-Δ24, a novel infectivity-enhanced conditionally replicative adenovirus, in anticipation of a phase I clinical trial in patients with ovarian cancer
    Kim, K.
    Tosca, P.
    Rudge, T.
    Peggins, J.
    Broadt, T.
    Wang, M.
    Harris, R.
    Aurigemma, R.
    Curiel, D.
    Alvarez, R.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S150 - S151
  • [8] Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer
    Page, John G.
    Tian, Baohong
    Schweikart, Karen
    Tomaszewski, Joseph
    Harris, Ray
    Broadt, Trevor
    Polley-Nelson, Judith
    Noker, Patricia E.
    Wang, Minghui
    Makhija, Sharmila
    Aurigemma, Rose
    Curiel, David T.
    Alvarez, Ronald D.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (04) : 389.e1 - 389.e10
  • [9] Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer -: Discussion
    Chambers, Setsuko K.
    Page
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (04)
  • [10] A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma
    Nyati, Shyam
    Stricker, Hans
    Barton, Kenneth N.
    Li, Pin
    Elshaikh, Mohamed
    Ali, Haythem
    Brown, Stephen L.
    Hwang, Clara
    Peabody, James
    Freytag, Svend O.
    Movsas, Benjamin
    Siddiqui, Farzan
    [J]. PLOS ONE, 2023, 18 (09):
12345